Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Mepivacaine Hydrochloride
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 04, 2024
Lead Product(s) : Mepivacaine Hydrochloride
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable